Chimeric Therapeutics Ltd makes material progress on pipeline candidates: Diamond Equity Research
Chimeric Therapeutics Ltd (ASX:CHM) has made headway on multiple fronts in the past quarter, with material progress visible in its pipeline candidates,...
Source: proactiveinvestors.com.au